Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 22-Sep-23 4:35 PM View:  | Clearside Biomedical, Inc. (CLSD) | 22-Sep-23 | Option Exercise | 22,727 | $0.40 | $9,090.80 | 80% 28.31K to 51.04K | |
| 07-Jul-23 4:06 PM View: | Electro-Optical Sciences, I... (SSKN) | 05-Jul-23 | Grant | 36,408 | $1.03 | $37,500.20 | 50% 73.32K to 109.72K | |
| 05-Jun-23 5:12 PM View: | Aclaris Therapeutics, Inc. (ACRS) | 02-Jun-23 | Option Exercise | 4,507 | -- | -- | 23% 19.57K to 24.07K | |
| 19-May-23 4:18 PM View: | Phasebio Pharmaceuticals Inc (PHAS) | 19-May-23 | Option Exercise | 2,538 | -- | -- | 100% 0 to 2.54K | |
| 06-Jun-22 5:18 PM View: | Aclaris Therapeutics, Inc. (ACRS) | 03-Jun-22 | Option Exercise | 3,356 | -- | -- | 21% 16.21K to 19.57K | |
| 28-Mar-22 5:03 PM View: | Electro-Optical Sciences, I... (SSKN) | 25-Mar-22 | Purchase | 16,950 | $1.73 | $29,384.50 | 4% 467.49K to 484.44K | |
| 24-Mar-22 8:32 PM View: | Electro-Optical Sciences, I... (SSKN) | 24-Mar-22 | Purchase | 14,783 | $1.58 | $23,386.70 | 3% 452.71K to 467.49K | |
| 11-Jan-22 4:45 PM View: | Clearside Biomedical, Inc. (CLSD) | 10-Jan-22 | Option Exercise | 22,727 | $0.15 | $3,409.05 | 407% 5.59K to 28.31K | |
| 21-Jul-21 5:28 PM View: | Electro-Optical Sciences, I... (SSKN) | 20-Jul-21 | Grant | 41,583 | -- | -- | 100% 0 to 41.58K | |
| 08-Dec-20 4:23 PM View: | Valeant Pharmaceuticals Int... (BHC) | 04-Dec-20 | Option Exercise | 114,055 | $14.38 | $1,640,110.00 | 49% 235.03K to 349.09K | |
| 08-Dec-20 4:23 PM View: | Valeant Pharmaceuticals Int... (BHC) | 04-Dec-20 | Option Sale | 114,055 | $19.87 | $2,266,400.00 | (33%) 349.09K to 235.03K | |
| 30-Nov-20 4:50 PM View: | Valeant Pharmaceuticals Int... (BHC) | 27-Nov-20 | Option Exercise | 13,663 | $14.38 | $196,474.00 | 6% 235.03K to 248.7K | |
| 30-Nov-20 4:50 PM View: | Valeant Pharmaceuticals Int... (BHC) | 27-Nov-20 | Option Sale | 13,663 | $19.63 | $268,207.00 | (5%) 248.7K to 235.03K | |
| 30-Nov-20 4:50 PM View: | Valeant Pharmaceuticals Int... (BHC) | 24-Nov-20 | Option Exercise | 21,658 | $14.38 | $311,442.00 | 9% 235.03K to 256.69K | |
| 30-Nov-20 4:50 PM View: | Valeant Pharmaceuticals Int... (BHC) | 24-Nov-20 | Option Sale | 21,658 | $19.63 | $425,196.00 | (8%) 256.69K to 235.03K | |
| 30-Nov-20 4:50 PM View: | Valeant Pharmaceuticals Int... (BHC) | 23-Nov-20 | Option Exercise | 1,483 | $14.38 | $21,325.50 | < 1% 235.03K to 236.52K | |
| 30-Nov-20 4:50 PM View: | Valeant Pharmaceuticals Int... (BHC) | 23-Nov-20 | Option Sale | 1,483 | $19.63 | $29,115.40 | (< 1%) 236.52K to 235.03K | |
| 10-Sep-20 4:34 PM View: | Valeant Pharmaceuticals Int... (BHC) | 08-Sep-20 | Sale (Planned) | 5,667 | $16.17 | $91,635.40 | (2%) 240.7K to 235.03K | |
| 18-Aug-20 7:53 PM View: | Clearside Biomedical, Inc. (CLSD) | 18-Aug-20 | Market Purchase | 5,586 | $1.78 | $9,943.08 | 100% 0 to 5.59K | 44% |
| 19-Aug-20 7:12 PM View: | Valeant Pharmaceuticals Int... (BHC) | 17-Aug-20 | Payment of Exercise | 4,567 | $17.48 | $79,831.20 | (2%) 245.27K to 240.7K | |
| 08-Jun-20 5:29 PM View: | Aclaris Therapeutics, Inc. (ACRS) | 06-Jun-20 | Option Exercise | 7,333 | -- | -- | 83% 8.88K to 16.21K | |
| 04-Mar-20 4:24 PM View: | Aclaris Therapeutics, Inc. (ACRS) | 02-Mar-20 | Option Exercise | 8,876 | -- | -- | 100% 0 to 8.88K | |
| 03-Mar-20 5:26 PM View: | Valeant Pharmaceuticals Int... (BHC) | 28-Feb-20 | Payment of Exercise | 2,264 | $24.44 | $55,332.20 | (< 1%) 247.53K to 245.27K | |
| 28-Feb-20 7:28 PM View: | Valeant Pharmaceuticals Int... (BHC) | 26-Feb-20 | Grant | 13,506 | -- | -- | 6% 234.03K to 247.53K | |
| 24-Feb-20 8:54 PM View: | Valeant Pharmaceuticals Int... (BHC) | 20-Feb-20 | Payment of Exercise | 56,532 | $26.46 | $1,495,840.00 | (19%) 290.56K to 234.03K | |
| 24-Feb-20 8:54 PM View: | Valeant Pharmaceuticals Int... (BHC) | 19-Feb-20 | Grant | 105,783 | -- | -- | 65% 163.87K to 269.65K | |
| 24-Feb-20 8:54 PM View: | Valeant Pharmaceuticals Int... (BHC) | 19-Feb-20 | Option Exercise | 20,911 | -- | -- | 8% 269.65K to 290.56K | |
| 07-Jan-20 4:18 PM View: | Valeant Pharmaceuticals Int... (BHC) | 03-Jan-20 | Payment of Exercise | 14,559 | $29.92 | $435,605.00 | (8%) 178.42K to 163.87K | |
| 20-Aug-19 4:17 PM View: | Valeant Pharmaceuticals Int... (BHC) | 16-Aug-19 | Grant | 30,703 | -- | -- | 26% 117.02K to 147.72K | |
| 20-Aug-19 4:17 PM View: | Valeant Pharmaceuticals Int... (BHC) | 16-Aug-19 | Market Purchase | 30,703 | $21.18 | $650,142.00 | 21% 147.72K to 178.42K | |
| 01-Mar-19 5:11 PM View: | Valeant Pharmaceuticals Int... (BHC) | 27-Feb-19 | Grant | 15,221 | -- | -- | 15% 101.8K to 117.02K | |
| 07-Jan-19 4:22 PM View: | Valeant Pharmaceuticals Int... (BHC) | 03-Jan-19 | Payment of Exercise | 13,311 | $18.47 | $245,854.00 | (12%) 115.11K to 101.8K | (28%) |
| 05-Jan-18 3:58 PM View: | Valeant Pharmaceuticals Int... (BHC) | 03-Jan-18 | Payment of Exercise | 14,730 | $20.78 | $306,089.00 | (11%) 129.84K to 115.11K | (14%) |
| 04-Jan-17 8:41 PM View: | Valeant Pharmaceuticals Int... (BHC) | 02-Jan-17 | Grant | 129,838 | -- | -- | 100% 0 to 129.84K |